⌕
Novavax · NVAX · Nasdaq
Tenet 58 · Mixed
Compare
$8.53−2.68%At closeTenet 58 · Mixed
$8.53−0.24 (−2.68%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

Novavax (NVAX) Stock

Novavax (NVAX) closed at $8.53 on Nov 13, 2026; its Tenet Score is 58 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

27 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$8.53
Nov 13, 2026
Market cap
$1.4B
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
6.20 – 13.38
low → high
Tenet Score
58/100
Mixed · 409 Healthcare peers

Industry: Drugs · see every company filed here →

Novavax, Inc. scores 58/100. Mixed. Strongest on value, quality is the soft spot versus 409 Healthcare peers.

Tenet Score · vs sector

n=409
58/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
99
Quality
33
Health
54
Growth
47

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueA+QualityDHealthCGrowthDMomentumA
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
—
Not meaningful: shareholders' equity is zero or negative.
P/S
3.4×
price to fiscal 2025 sales
ROE
—
Not meaningful: shareholders' equity is zero or negative.
Operating margin
40.3%
fiscal 2025, before interest and tax
Net margin
−18.6%
of revenue kept
Current ratio
2.15
current assets to liabilities
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Novavax, Inc.

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine can…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 68 US ETFs · top wrappers by weightSee all ETFs holding NVAX →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

Compare Novavax with

What sector and industry is Novavax in?

Novavax is in the Healthcare sector and the Drugs industry.

What is Novavax's Tenet Score?

Novavax's Tenet Score is 58 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.